Atlas Trials

Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors

Clinical trial NCT03335670 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03335670
Sponsor
Yusuf Menda
Status
ACTIVE_NOT_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2017-11-03
Primary completion
2029-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.